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Introduction
The maintenance of  a diverse, naive T cell repertoire arising from the thymus (recent thymic emigrants, 
RTEs) is critical for health (1). Thymic involution decreases naive CD4+ T cell production with age in humans 
and is compensated for by the homeostatic maintenance of  naive cells that have emigrated from the thymus 
earlier in life (2, 3). It was recently shown that naive T cells are retained in lymphoid tissues in a biased man-
ner, perhaps reflecting mechanisms required for long-term retention of  these cells following thymic involution 
(4). Naive T cells that have undergone decades of  homeostatic maintenance by a low rate of  division and 
compensatory cell death show reduced T cell receptor diversity, which has the potential to negatively impact 
immune defense and health (1, 5). CD31 (PECAM-1) expression identifies cells that have divided more often 
in the periphery (CD31−) from those that have not (CD31+), although CD31+ T cells still divide as a function 
of  age as evidenced by the approximately 5-fold dilution of  signal joint T cell receptor rearrangement excision 
circles (sjTRECs) between the ages of  20 and 60 (2, 6). This 5-fold dilution of  sjTRECs equates to on average 
The maintenance of peripheral naive T lymphocytes in humans is dependent on their homeostatic 
division, not continuing emigration from the thymus, which undergoes involution with age. 
However, postthymic maintenance of naive T cells is still poorly understood. Previously we reported 
that recent thymic emigrants (RTEs) are contained in CD31+CD25− naive T cells as defined by their 
levels of signal joint T cell receptor rearrangement excision circles (sjTRECs). Here, by differential 
gene expression analysis followed by protein expression and functional studies, we define that the 
naive T cells having divided the least since thymic emigration express complement receptors (CR1 
and CR2) known to bind complement C3b- and C3d-decorated microbial products and, following 
activation, produce IL-8 (CXCL8), a major chemoattractant for neutrophils in bacterial defense. We 
also observed an IL-8–producing memory T cell subpopulation coexpressing CR1 and CR2 and with a 
gene expression signature resembling that of RTEs. The functions of CR1 and CR2 on T cells remain 
to be determined, but we note that CR2 is the receptor for Epstein-Barr virus, which is a cause of T 
cell lymphomas and a candidate environmental factor in autoimmune disease.
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somewhat more than 2 cell divisions in the CD31+CD4+ naive T cell population over a period of  4 decades. 
The tyrosine-protein kinase–like 7 receptor (encoded by PTK7) has been reported as a marker of  RTEs within 
the CD31+ naive T cell subset in adults with PTK7+CD31+ naive CD4+ T cells having a 3-fold enrichment 
of  sjTRECs as compared with their PTK7−CD31+ counterparts (7). We and others have shown that CD25 is 
expressed at higher levels in naive CD4+ T cells that have divided in the periphery and that the proportions 
of  CD31+CD25+ and CD31−CD25+ naive CD4+ T cells are higher with age (8, 9). CD31+CD25− naive CD4+ 
T cells contained the highest content of  sjTRECs among the 4 naive CD4+ T cell subsets examined: a 4-fold 
enrichment of  sjTRECs in CD31+CD25− naive CD4+ T cells as compared with their CD31+CD25+ counter-
parts was observed, thereby identifying the CD31+CD25− naive CD4+ T cell subset as containing the highest 
proportion of  RTEs in adults (8).
In the current study, we isolated 4 naive CD4+ T cell subsets from 20 adult healthy volunteers based 
on CD31 and CD25 expression and conducted transcriptome profiling to determine their molecular sig-
natures. These signatures define gene expression patterns in naive T cells as they first undergo postthymic 
maturation and then continue to expand slowly over years and decades in the periphery waiting to encoun-
ter their cognate antigen. Unexpectedly, in the subset that has divided the least since leaving the thymus, 
CD31+CD25− naive CD4+ T cells, complement receptor 2 (CR2) was differentially and strongly expressed 
as compared with both the CD31+CD25+ and CD31−CD25− subsets. CD31+CD25− naive CD4+ T cells 
sorted by CR2 expression showed a 6-fold enrichment of  sjTRECs in the CR2+ fraction as compared with 
the CR2− fraction, with the cells having the highest levels of  CR2 showing the greatest enrichment (9-fold). 
In patients treated with a T- and B-lymphocyte-depleting drug, the anti-CD52 antibody (alemtuzumab), 
we observed that during homeostatic reconstitution newly emerging naive T cells from the adult thymus 
express high levels of  CR2 and, after activation, approximately 50% produced IL-8, a chemokine (CXCL8) 
that can activate neutrophils and γδ T cells in microbial defense. IL-8–producing naive neonatal T cells have 
been recently identified (10). Although the link with RTEs was not made, this study showed enrichment of  
IL-8 production from CD31+ naive CD4+ T cells. Very recently, IL-8 production has been associated with 
RTEs in children (11). Our results also support the existence of  an IL-8–producing memory T cell subset 
identified in a recent study (12), which may, depending on future investigations, prove to be a Th8 lineage.
Results
Naive CD4+ T cell subsets defined by CD31 and CD25 differentially express CR2 and AOAH. We assessed the pro-
portion of  4 naive CD4+ T cell subsets defined by CD31 and CD25 expression (8) in neonates, children, 
and adults in a population study of  391 donors (Figure 1, A and B). CD31+CD25− naive CD4+ T cells 
decreased with age and this decrease was compensated for by the homeostatic maintenance of  3 subsets of  
naive T cells: CD31+CD25+, CD31−CD25−, and CD31−CD25+. As expected (13), the proportion of  both 
naive CD4+ and CD8+ T cells negatively correlated with donor age (Supplemental Figure 1A; supplemental 
material available online with this article; https://doi.org/10.1172/jci.insight.93739DS1). To define mol-
ecules associated with the least expanded naive subset, we performed a statistically powered, genome-wide 
microarray RNA analysis of  FACS-purified naive CD4+ T cells from 20 adult healthy volunteers sorted 
into 4 subsets based on CD31 and CD25 expression (Supplemental Figure 1B). Principal component analy-
sis of  differentially expressed genes among the 4 subsets showed a clear separation between the groups, 
particularly between CD31+ cells and their CD31− counterparts (Supplemental Figure 1C). Genes with 
higher expression in CD31+CD25− naive cells as compared with the CD31− CD25− subset included AOAH, 
which encodes the enzyme acyloxyacyl hydrolase that inactivates LPS and is highly expressed in innate 
immune cells such as neutrophils and DCs (14), and CR2, which encodes a cell surface protein that binds 
C3d and other complement components (15) and is also a receptor for EBV in humans (16) (Figure 1C 
and Supplemental Spreadsheet 1, A–D). CR2, AOAH, TOX (a transcription factor reported to regulate T 
cell development in the thymus; see ref. 17) and CACHD1, an uncharacterized gene that may encode a pro-
tein that regulates voltage-dependent calcium channels, were higher in CD31+CD25− cells when they were 
compared with both CD31−CD25− (Figure 1C) and CD31+CD25+ cells (Supplemental Figure 1D). A list of  
shared gene expression differences in naive cell subsets that have undergone more rounds of  homeostatic 
division than CD31+CD25− cells is shown in Supplemental Spreadsheet 1E.
Genes more highly expressed in CD31−CD25− cells as compared with CD31+CD25− cells (Figure 1C) 
are consistent with the occurrence of  activation and differentiation events during the homeostatic main-
tenance of  naive T cells. The genes include PYHIN1, encoding an interferon-induced intracellular DNA 
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receptor that is a member of  a family of  proteins that induces inflammasome assembly (18, 19); GBP5, 
encoding a protein that promotes NLRP3 inflammasome assembly (20); CTLA4, a negative regulator of  T 
cell activation; KLRB1, encoding CD161, a marker of  IL-17–producing T cells (21); and IL2RB, a signaling 
subunit of  the trimeric high-affinity IL-2 receptor.
Naive T cells expressing CR2 are more prevalent in children than adults. We verified the CR2 mRNA expres-
sion results using flow cytometric analysis, with the CD31+CD25− naive CD4+ T cell subset from adults 
and children having the highest proportion of  cells positive for CR2 (Figure 2, A and B). In the case of  
cord blood, greater than 60% of  CD31− naive cells also expressed CR2. The 3 subsets previously shown 
to be products of  homeostatic turnover based on sjTREC content (8) had lower proportions of  CR2+ 
cells, with the percentage CR2+ decreasing from CD31+CD25+ cells to CD31−CD25− to CD31−CD25+. 
The lower percentages of  CR2+ cells within the CD31+CD25− naive subset by age (Figure 2B) was more 
pronounced when considered out of  total CD4+ T cells since the proportion of  naive cells within the 
CD4+ population decreases with age (Supplemental Figure 2A). The CR2+ fraction of  the CD31+CD25− 
naive CD4+ T cell subset also had the highest level of  CR2 on a per-cell basis among the 4 naive subsets 
in a given adult or child and this density decreased with age (Figure 2A). Cord blood was again the 
exception where CD31+ and CD31− cells had similarly high CR2 levels. A pattern similar to that of  naive 
Figure 1. Gene expression profiling of 4 naive CD4+ T cell subsets 
identify age-related molecular signatures. (A) Gating strategy defin-
ing human naive CD4+ T cells; naive T cells were further stratified by 
CD31 and CD25. Representative examples (from n = 391; 371, 15, and 5 
from cohorts 1–3, respectively; see Methods for details) of naive CD4+ 
T cells. (B) The proportion of naive CD4+ T cells as a function of age 
(color coding shown above graph). (C) Volcano plot of differences in 
gene expression (microarray platform) between CD31+CD25− and CD31–
CD25− naive CD4+ T cells; red and blue symbols for genes with higher 
and lower, respectively, expression in CD31+CD25− naive CD4+ T cells  
(n = 20, cohort 1).
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CD4+ T cells from adults and children of  fewer CR2+ cells and a lower density of  CR2 per cell with age 
was also observed on naive CD8+ T cells (Supplemental Figure 2B).
Although CR2 expression on CD31+CD25− naive CD4+ T cells in adults varies greatly, this most 
likely reflects the biological variation of  thymic output and rate of  homeostatic division. Supporting 
the hypothesis that CR2 expression on human naive T cells is influenced by time in the periphery, we 
observed that the percentage of  CD31+CD25− naive CD4+ T cells that are CR2+ was stable in 10 donors 
during a period of  time in which little homeostatic division would have occurred (second sample taken 
11 to 17 months after the first) (Supplemental Figure 2C). The regulation of  CR2 in naive T cells is 
Figure 2. CR2 marks the most naive CD4+ T cell subset. (A) Representative examples of CR2 expression in naive T cell subsets. (B) Percentage CR2+ cells in 
each subset and frequency of CR2+ cells in the CD31+CD25− naive CD4+ T cell subset as a function of age (from n = 389; 371, 15, and 3 from cohorts 1–3, respec-
tively). Significance determined by paired t test. (C) Representative sorting strategy for CD31+CD25− naive CD4+ T cells identified as CR2−, CR2lo, and CR2hi 
(donors 1–4). For donors 5–7, the CR2+ gate is a combination of low- and high-CR2-expressing cells. Sorted cells were assessed for signal joint T cell receptor 
rearrangement excision circles (sjTRECs) (n = 7; 1 and 6 donors from cohorts 1 and 3, respectively).
Downloaded from http://insight.jci.org on September 13, 2017.   https://doi.org/10.1172/jci.insight.93739
5insight.jci.org   https://doi.org/10.1172/jci.insight.93739
R E S E A R C H  A R T I C L E
distinct from that in B cells where CR2 expression is observed on the majority of  both mature naive and 
memory B cells (22) and expression levels on CR2+ B cells are approximately 30-fold higher than those 
on CR2+ naive T cells (Supplemental Figure 2D). Indeed, to optimize detection of  CR2 on naive T cells 
we stained simultaneously with 2 anti-CR2 antibody clones. Activation of  B cells has been shown to 
increase CR2 promoter activity and CR2 protein levels (23), whereas CR2 mRNA decreases in naive T 
cells following anti–CD3/CD28 activation (Supplemental Spreadsheet 3), suggestive of  distinct mecha-
nisms of  regulation in these 2 lymphocyte subsets. Because PTK7 has been described as a marker of  
RTE (7, 11), we examined our microarray gene expression data for differential expression in the 4 sub-
sets of  naive cells in adults to determine if  a pattern similar to that observed for CR2 could be detected. 
Although no differential expression was evident in any of  the comparisons (Supplemental Spreadsheet 
1, A–D), this appears to be due to the fact that the levels of  PTK7 mRNA were not above background, 
consistent with the very low levels of  PTK7 mRNA and protein expression previously reported in adult 
naive CD4+ T cells (see Figure 2 in ref. 7).
CR2+ naive CD4+ T cells have a higher sjTREC content than their CR2− counterparts. To determine whether 
CR2 is a molecular marker of  the subset of  CD31+CD25− naive CD4+ T cells that have divided the least 
Figure 3. Higher complement receptor 2 (CR2) expression by human naive CD4+ T cells during de novo reconstitution. (A) Treatment and sampling 
time points of multiple sclerosis (MS) patients. (B) Frequency of CD31+CD25− naive CD4+ T cells expressing CR2 in MS patients before (baseline, BL) and 12 
months after lymphocyte depletion with anti-CD52 (Campath). Significance determined by paired t test. (C) CR2 expression on CD31+CD25− naive CD4+ T 
cells from 2 patients before and at various times during reconstitution; time points from 6 additional patients are shown in Supplemental Figure 3C.
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in the periphery since emigrating from the thymus, we sorted CR2hi, CR2lo, and CR2−CD31+CD25− naive 
CD4+ T cells along with CD31−CD25− naive CD4+ T cells from 4 adult donors and, when cell numbers 
were limiting, CR2+ and CR2−CD31+CD25− naive CD4+ T cells from 3 additional adult donors, and 
assessed sjTREC levels (Figure 2C). Purified CD31− naive CD4+ T cells had fewer sjTRECs than any 
of  the CD31+ populations (Figure 2C) as expected based on previous studies showing that the loss of  
CD31 expression from naive cells is associated with a substantial loss of  sjTRECs (2, 6, 8). CD31+CR2− 
and CD31+CR2hi cells had on average 7- and 67-fold enrichment, respectively, of  sjTRECs as compared 
with CD31−CR2− cells. CR2+ cells had more sjTRECs than CR2− cells in all cases (n = 7, P = 0.0023 
using sjTREC values obtained from CR2hiCD31+ cells compared with CR2−CD31+ cells for donors 1–4 
and CR2+CD31+ cells compared with CR2−CD31+ cells for donors 5–7; P = 0.018 using CR2loCD31+ cells 
compared with CR2−CD31+ cells for donors 1–4 and CR2+CD31+ cells compared with CR2−CD31+ cells 
for donors 5–7, Mann-Whitney rank test). This result indicates that in adults CR2+ cells have undergone 
fewer rounds of  homeostatic division as compared with CR2− cells within the CD31+CD25− subset of  naive 
CD4+ cells. Enrichment of  sjTRECs was 9.2-fold comparing CR2hi and CR2−CD31+ cells in donors 1–4 
and 5.6-fold when comparing CR2+ and CR2−CD31+ cells in donors 5–7. Where cell numbers were suf-
ficient to separate the CR2hi and CR2lo naive CD4+ T cells, CR2lo cells had fewer sjTRECs than the CR2hi 
cells in each comparison (n = 4, P = 0.11), suggesting that higher CR2 expression on a per-cell basis on 
CD31+CD25− naive CD4+ T cells identifies cells that have divided the least number of  times since leaving 
the thymus. These observations along with our previous demonstration of  CD25 expression on homeostati-
cally expanded naive CD31+ cells T cells (8) explain why naive CD4+ T cells isolated only by CD31 expres-
sion show an age-dependent loss of  sjTRECs (2, 6).
RTEs from the adult thymus are CR2+. To further test the hypothesis that CR2 expression on naive T cells 
defines RTEs throughout life rather than being specific to cells generated during the neonatal period, we 
monitored newly generated naive CD4+ T cells in 8 multiple sclerosis (MS) patients depleted of  T and B 
cells using alemtuzumab (24) (Figure 3A and Supplemental Figure 3A). Twelve months after depletion, in 
all 8 patients, the proportion of  naive CD4+ (Figure 3, B and C, and Supplemental Figure 3C) and CD8+ 
(Supplemental Figure 3B) T cells expressing CR2 was increased as compared with baseline. These data 
demonstrate that de novo RTEs produced in the adult thymus can also be stratified by CR2 expression, 
similar to our findings based on CR2 expression on naive T cells in cord blood and in the peripheral blood 
of  children (Figure 2, A and B). Interim time points were available from most patients (Figure 3C and 
Supplemental Figure 3C), showing that when the first few naive CD4+ T cells were detected after depletion 
(3–9 months after treatment), they were essentially all CR2+ with a density of  CR2 per cell equalling that 
seen in cord blood (Figure 2A). This observation was independent of  whether a patient had good or poor 
naive CD4+ T cell reconstitution overall.
A potential utility of  our observation is to use CR2 as a biomarker of  thymic reserve. Therefore, we 
compared the frequency of  CR2+ cells within the CD31+CD25− naive CD4+ T cell subset prior to lympho-
cyte depletion with the ability of  the thymus to reconstitute naive CD4+ T cells (Supplemental Figure 3A). 
The 2 patients (P2 and P6) with the lowest level of  naive CD4+ T cell reconstitution at 12 months (5.4% 
and 2.4% of  baseline, quantified as number of  cells per ml of  blood) had the lowest levels of  CR2+ T cells 
within their CD31+CD25− naive CD4+ T cell subset (18% and 17%) prior to treatment. In contrast, the 6 
patients who reconstituted their naive CD4+ T cell pool from 13% to 64% of  baseline (average of  37%) by 
12 months had on average 38% (range 29%–54%) CR2+ cells in the CD31+CD25− naive CD4+ T cell subset 
prior to treatment. Although these results are encouraging for the use of  CR2 as a biomarker of  T cell pro-
duction by the thymus, additional patients will need to be examined to verify our findings.
Gene expression profiling of  CR2+ and CR2− naive cells. To evaluate the potential function of  CR2+ naive 
CD4+ T cells we compared RNA isolated from sorted CR2+ and CR2−CD31+CD25− naive CD4+ T cells 
ex vivo and after activation with anti–CD3/CD28 (Figure 4A, Supplemental Spreadsheets 2 and 3, and 
Supplemental Tables 1 and 2). This analysis revealed a unique transcriptional signature of  the CR2+ RTEs. 
Complement receptor 1 (CR1), AOAH, and TLR1 were more highly expressed in CR2+ cells. Coexpression of  
CR1 and CR2 was observed on the surface of  CD31+CD25− naive CD4+ T cells from healthy controls (Fig-
ure 4B) and MS patients reconstituting their T cells after alemtuzumab treatment (Supplemental Figure 4A). 
Coexpression of  CR1 and CR2 was also observed on naive CD8+ T cells (Supplemental Figure 4, B and C). 
Consistent with CR2 marking RTEs, we observed that PTK7 mRNA was approximately 2-fold more abun-
dant in the CR2+ as compared with the CR2−CD31+CD25− naive CD4+ T cells. In comparison, CR2 mRNA 
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Figure 4. CR2+ naive CD4+ T cells have a unique molecular signature. (A) Volcano plots of differences in gene expression (NanoString platform) 
between CR2+ versus CR2− naive CD4+ T cells (gating strategy shown as insert) ex vivo and after activation (anti–CD3/CD28). Genes expressed at a 
higher or lower level in CR2+ cells have red or blue symbols, respectively. Underlined genes have lower expression after activation. Genes in boxes are 
from the RNA-seq platform (n = 4 adult donors from cohorts 1 and 3). (B) Ex vivo CR1 protein expression on CR2+ and CR2− cells (n = 34, age range 
0–67, cohorts 1–3, paired t test). Red and gray histograms gated on CR1+ and CR1− cells, respectively. (C) Representative histograms and compiled fre-
quencies of cytokine production following activation of CR2+ and CR2− cells sorted from CD31+CD25−  naive CD4+ T cells (n = 3, age range 30–44, cohort 
3, paired t test). (D) Representative histograms of IL-8 production from isolated CD4+ T cells following activation with PMA and ionomycin. Compiled 
data of percentage IL-8+ cells out of naive (CD45RA+) CD4+ T cells (unpaired t test, n = 3 cord bloods from cohort 3, 4 multiple sclerosis [MS] patients 6 
to 9 months after treatment, 3 MS patients >10 years after treatment. Correlation of percentage IL-8+ cells (following activation) and percentage CR2+ 
cells (assessed prior to activation) in the MS patients (n = 7).
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read counts were 10-fold more abundant in CR2+ as compared with the CR2− cells and there were 20-fold 
fewer PTK7 mRNA reads as compared with CR2 mRNA reads (Supplemental Figure 4D and Supplemental 
Spreadsheet 2). Since both CR2 and PTK7 mRNA levels appear to correspond to protein levels in naive 
CD4+ T cells (Supplemental Table 1 in this study and ref. 7, respectively), the RNA sequencing (RNA-seq) 
data support the previous observation that PTK7 levels are very low on adult naive T cells.
Following activation, IL-8 mRNA was more highly expressed in CR2+ naive CD4+ T cells whereas IL2, 
IL21, LIF, and IFNG were more highly expressed in CR2− cells (Figure 4A, Supplemental Spreadsheet 3, and 
Supplemental Table 2). This is consistent with studies showing that RTEs from children secrete less IFN-γ 
and IL-2 (7) and more IL-8 (11). TNF, LTA, and IL23A were highly upregulated with activation but there was 
no difference between the CR2+ and CR2− naive subsets. IL-8 mRNA upregulation was of  particular inter-
est since it has been identified as a phenotype of  neonatal naive cells (10). We therefore measured IL-8 and 
IL-2 protein production from sorted CR2+ versus CR2− naive CD4+ T cells after activation with PMA and 
ionomycin. We verified the RNA results showing that IL-8 is preferentially produced by the CR2+ subset, 
whereas the opposite is the case for IL-2 (Figure 4C). The measurement of  percentage positive for IL-8 is 
an underestimate of  the difference between CR2+ versus CR2− naive CD4+ T cells, since for the CR2+ cells 
expressing IL-8 the production of  IL-8 on a per-cell basis was greater than for CR2− cells (mean fluorescence 
intensity 7,000 ± 177 [SEM] vs. 4,875 ± 403 [SEM], P = 0.008, unpaired t test). Because CR2 rapidly disap-
pears from the surface of  T cells activated in vitro when PMA and ionomycin are used to induce cytokine 
expression (Supplemental Figure 4E), analysis of  cytokine production after stimulation is prevented unless 
cells are sorted by CR2 expression first as in Figure 4C. Therefore, for other samples, namely isolated CD4+ 
T cells from cord blood and from peripheral blood of  MS patients reconstituting their naive T cell compart-
ment and MS patients in whom naive T cells had undergone over a decade of  homeostatic division, we 
correlated IL-8 production in naive CD4+ T cells with the frequency of  CR2+ cells within the same naive T 
cell subset prior to activation (Figure 4D). Notably, all MS patients that were less than 1 year after depletion 
(n = 4) had CR2 expression on 70% or more of  their naive CD4+ T cells (similar to the patients described in 
Figure 3 and Supplemental Figure 3). Approximately 50% of  these naive CD4+ T cells produced IL-8. IL-8 
production by naive cells from these patients was as prevalent as that observed from cord blood naive CD4+ 
T cells (n = 3). These data support the hypothesis that RTEs in adults recapitulate the developmental stage 
observed in neonatal RTEs. On the other hand, the frequency of  naive CD4+ T cells expressing CR2 and 
CD45RA+CD4+ T cells producing IL-8 in MS patients more than 10 years after depletion (n = 3) was less 
than 35% and 12%, respectively. A correlation between CR2 expression and IL-8 production was therefore 
observed in the 7 MS patients examined. Where homeostatic division had occurred for at least a decade 
(Figure 4D), MS patients were similar to healthy adults (Figure 4C). Since the expression of  CR2 on a per-
cell basis is lower in adults than in neonates and children (Figure 2A), and the number of  sjTRECs is fewer 
in cells with lower CR2 expression on a per-cell basis (Figure 2C), these data suggest that as naive cells divide 
homeostatically, CR2 expression decreases as well as their ability to produce IL-8.
CR2+ central memory cells produce IL-8. When analyzing IL-8 production by CD4+ T cells we noted that 
in MS patients more than 10 years past lymphocyte depletion, a small fraction of  activated CD45RA− 
memory CD4+ T cells produced IL-8 (Figure 4D). We therefore hypothesized that CD4+ memory T cells 
can be expanded from IL-8–producing CR2+ naive T cells in vivo. CR2 expression was observed on a 
proportion of  central and effector memory CD4+ T cells, and Tregs expressed the lowest levels of  CR2 
(Figure 5A and Supplemental Figure 5A). CR2 expression on memory cells correlated with CR2 expres-
sion by naive T cells (Figure 5B) and was age dependent (Figure 5C), suggesting that with age the CR2+ 
central memory cells either lose CR2 expression or the subset contracts due to competition with CR2− 
central memory cells. CR2+ central memory CD8+ T cells were also observed and their frequency was 
similarly age dependent (Supplemental Figure 5B). As seen with the equivalent CD4+ naive T cell subsets, 
RNA analysis of  sorted CR2+ and CR2− central memory CD4+ T cells showed CR1 to be the most differ-
entially expressed gene (Figure 5D, Supplemental Spreadsheet 4, and Supplemental Table 1), a phenotype 
confirmed at the protein level (Figure 5E). An overall expression analysis of  the CR2+ and CR2− naive and 
central memory cell subsets confirmed that the 2 memory populations clustered together away from the 2 
naive subsets, confirming that the CR2+ central memory cells are bona fide central memory cells, not an 
unusual naive cell subset (Supplemental Figure 5C). Sorted CR2+ central memory cells produced higher 
levels of  IL-8 after activation as compared with CR2− central memory cells, and unlike naive CR2+ cells 
(Figure 4C), all central memory cells producing IL-8 also produced IL-2 (Figure 5F).
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Figure 5. CR2 and CR1 are coexpressed on a subset of central memory CD4+ T cells. (A) Gating strategy and CR2 expression. Correlation of CR2 
expression on central memory versus naive CD4+ T cells (B) and CR2+ central memory CD4+ T cells versus age (C) (n = 389; 371, 15, and 3 from cohorts 
1–3, respectively). (D) Gating example of central memory cells sorted by CR2 expression, and gene expression analysis (NanoString). Color coding is 
described in Figure 4. (E) FACS analysis and compiled data of CR1 and CR2 coexpression (n = 34, age range 0–67, cohorts 1–3, paired t test). Red and 
gray histograms gated on CR1+ and CR1− cells, respectively. (F) Example and compiled data of IL-8 production from sorted and activated CR2+ and CR2− 
memory CD4+ T cells (n = 3, age range 30–44, cohort 3, paired t test).
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Among the differentially expressed genes between the CR2− and CR2+ central memory cells, a gene 
of  particular note is complement factor H (CFH), which is upregulated in both CR2− and CR2+ central 
memory cells as compared with naive cells but has 2.7-fold higher levels in CR2+ central memory cells 
compared with CR2− central memory cells (Figure 5D, Supplemental Spreadsheet 4, and Supplemental 
Table 1). Genes with shared expression differences between CR2+ naive and CR2+ central memory T cells 
versus their CR2− counterparts ex vivo are highlighted in Supplemental Figure 6 and include a potentially 
relevant transcription factor for CR2+ CD4+ cells, ZNF462, which is expressed 13.0-fold higher in CR2+ ver-
sus CR2− naive cells and 7.2-fold higher in CR2+ versus CR2− central memory cells. Four genes, ADAM23, 
ARHGAP32, DST, and PLXNA4, shared by the 2 CR2+ subsets may enhance migratory properties that aug-
ment host surveillance (25).
Discussion
An understanding of  the impact of  thymic involution on health remains incomplete despite its influence 
on the aging of  the immune system (1) and other clinical aspects (24, 26–28). In our analysis of  naive T 
cell subsets, we report for the first time to our knowledge coexpression of  CR1 and CR2 on the most naive 
T cells and that these, as well as other molecules differentially expressed by these cells, will enable a better 
understanding of  human RTEs.
Coexpression of  CR1 and CR2 occurs on follicular DCs and B cells and their functions are critical to 
generating antibody responses, including the retention of  immune complexes on follicular DCs (29, 30). 
CR1 participates in the degradation of  activated C3 to C3d, which then binds CR2 and facilitates the inter-
action via immune complexes of  follicular DCs with B cells, lowering their threshold of  activation. The 
presence of  CR2 and CR1 on the surface of  naive T cells provides them with the potential to participate in 
immune responses in a manner analogous to follicular DCs and B cells. Our findings add to an increasing 
appreciation of  the role in T cell functions of  molecules classically described as belonging to the innate 
immune system. Previously, it has been shown that human T cells express and process C3 to C3a and C3b 
and binding of  C3b by CD46 regulates cytokine production and effector differentiation (31, 32). There have 
been previous reports of  CR2 expression on fetal T cells (33) and thymocytes (34), but not in the context of  
RTEs as presented here. Evidence for a CR2 and CR1 function in T cells was their 3- to 10-fold enhance-
ment of  C3-dependent HIV infection in the HPB-ALL T cell leukemia cell line (35).
The hypothesis that RTEs have a distinctive ability to respond to bacterial pathogens as com-
pared with long-term peripheral naive T cells was supported by our finding that following activation 
CR2+CD31+CD25− RTEs preferentially produced IL-8 (CXCL8). The IL-8 chemokine has been recently 
characterized as a “proinflammatory immunoprotective cytokine of  neonatal T cells” via neutrophil 
recruitment and costimulation of  γδ T cells (10). The authors also demonstrated that IL-8 expression by 
neonatal T cells was increased when in addition to TCR stimulation cells were provided with bacterial 
flagellin or the TLR1/2 agonist Pam3Cys. In our study, not only have we observed that approximately 
50% of  naive CD4+ T cells in cord blood produce IL-8 upon activation, we also demonstrated a similar 
proportion of  IL-8–producing naive T cells in the blood of  MS patients, with newly generated naive T 
cells appearing following T and B cell depletion with alemtuzumab (Figure 3 and Supplemental Figure 
3). In healthy adults or in MS patients greater than 10 years following lymphocyte depletion, a smaller 
portion of  naive CD4+ cells produced IL-8, but we also noted that the level of  CR2 on a per-cell basis is 
much lower on CR2+ naive T cells from adults as compared with the level of  CR2 expression observed on 
CR2+ naive T cells present in neonates, children, and adults actively reconstituting their immune system. 
This is consistent with the observation that in adult naive CD4+ T cells sorted by CR2 levels, the greatest 
number of  sjTRECs was in cells with the highest CR2 levels per cell (9-fold enrichment of  sjTRECs in 
the CR2hi fraction of  CD31+CD25− naive CD4+ T cells as compared with the CR2− fraction in the same 
subset). Overall, we conclude that as naive cells emigrate from the thymus they express high levels of  
CR2 and are capable of  secreting IL-8, but as homeostatic division of  naive T cells occurs through time, 
CR2 levels and the preferential secretion of  IL-8 declines. Our findings are compatible with recent stud-
ies showing that following neonatal thymectomy IL-8 production by naive CD4+ T cells was reduced 
by greater than 90% (11). Taken together, recent development in the thymus, not absolute age, confers 
a unique phenotype to RTEs: preferential IL-8 production and high CR2 expression. We also noted at 
the mRNA level higher expression in RTEs of  the genes encoding TLR1, a bacterial pattern recognition 
receptor, and AOAH, a secreted enzyme that inactivates LPS.
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We hypothesize that following their emigration from the thymus, T cells initially express high levels 
of  CR2 and CR1, secrete IL-8 and TNF, have the capacity to hydrolyze LPS, based on mRNA results, and 
produce lower levels of  T cell cytokines such as IL-2 and IFN-γ. It is possible that this differentiation state 
provides tissue protection while avoiding overwhelming T cell activation, attributes likely to be critical to the 
newborn encountering a wide range of  antigens from microbes on the skin and mucosal tissues as well as 
encountering airborne and food antigens. Our results are consistent with previous mouse and human studies 
demonstrating decreased IL-2 and INF-γ production by activated RTEs compared with T cells resident in 
the periphery for a longer period of  time (11, 36, 37). Studies focused on the biology of  RTEs in mice dem-
onstrated that in the absence of  inflammation RTEs display heightened susceptibility to tolerance induction 
to tissue-restricted antigens (36), suggesting that the RTE differentiation state could also contribute to toler-
ance induction to commensal bacteria. Such tolerance induction may require RTE migration into all tissues 
and associated draining lymph nodes that are exposed to commensals as well as pathogens. The importance 
of  tissue residency by naive T cells is strongly supported by recent discoveries showing that pediatric samples 
of  colon, ileum, jejunum, and lung, in contrast to tissues from young adults, contain a large portion of  naive 
CD4+ and CD8+ T cells, most of  which were defined as RTEs by the virtue of  expressing CD31 (37). Results 
from TCR repertoire analyses of  naive T cells isolated from lymphoid tissues of  donors aged 2 months to 73 
years suggest naive T cell homeostatic division is at least in part site-specific and that the dynamics of  naive 
T cell recirculation in humans may differ from those understood from mouse studies (4).
Aspects of  the innate signature of  RTEs are retained by a subset of  CR2+ central memory T cells that 
express CR1 and secrete IL-8 upon activation, suggesting that RTEs are precursors of  a subset of  memory 
T cells (see genes shared by CR2+ naive and memory T cells in Supplemental Figure 6). Further support-
ing this hypothesis, we noted that when compared with their CR2− counterparts, CR2+ central memory T 
cells express 3-fold higher CFH, a complement regulatory glycoprotein possessing a cofactor activity for 
complement inactivation on the surface of  the host cells, but not on that of  the pathogen (15). However, 
since we did not observe differential expression of  the genes encoding Th-defining transcription factors 
(38) — RORC (Th17), GATA3 (Th2), PRDM1 (Tfh), and BCL6 (Tfh) (although differential expression of  
TBX21 [Th1] was observed, Supplemental Spreadsheet 4) — when comparing CR2+ and CR2− memory T 
cells, this implies that CR2+ naive T cells can differentiate to Th memory lineages not characterized by IL-8 
secretion while maintaining CR2 expression. Wong and colleagues (12) noted the possible developmental 
relationship of  IL-8–producing memory T cells in tissues with the abundant IL-8–secreting naive T cells in 
cord blood and noted that “while not defined as a Th lineage, IL-8–producing cells had very little overlap 
with other Th subsets in terms of  cytokine secretion and trafficking receptor expression.” We suggest that 
the shared gene expression pattern of  memory and naive CR2+ cells that preferentially secrete IL-8, includ-
ing the transcription factor ZNF462, support a developmental relationship.
Future functional studies of  CR2 and CR1 on naive and memory CD4+ and CD8+ T cells will further 
our understanding of  T cell biology, thymic function as people age and during bone marrow transplanta-
tion (28), HIV infection (26), thymectomy (7, 11), and immune reconstitution following immune depletion 
(24) or chemotherapy (27). Recently, the functions of  2 other complement receptors expressed in T cells, 
C5aR1 and C5aR2, have been described. C5 activation in T cells was shown to be required for NLRP3 
inflammasome assembly and Th1 differentiation (39). The presence of  EBV receptors (CR2 molecules) on 
T cells highlights a potential pathway of  EBV infection that in some cases results in T cell lymphoma (40). 
It is possible that the binding of  EBV via CR2 to EBV-specific, CR2+ naive T cells during antigen-specific 
activation beneficially modulates responsiveness, thereby accounting for the observation that the severity of  
EBV increases with age (41), which correlates with the loss of  CR2 on naive T cells with homeostatic divi-
sion. The near absence of  CR2+ T cells later in life could contribute to the less effective immunity, especially 
to microbial infections, observed in older individuals (3).
Methods
Human samples. Donors of  peripheral blood volunteered for 1 of  3 observational studies (cohorts 1–3 below) 
and 1 clinical trial. The 3 cohorts are described below and how each cohort contributed to the results 
presented in the manuscript. Although cohorts 1–3 involved projects with research questions concerning 
type 1 diabetes and had type 1 diabetic participants, none of  the donors included in this study had type 1 
diabetes. Aside from 4 of  the 371 donors in cohort 1 forming a majority of  the immunophenotyping panel 
(detailed below), all participants in cohorts 1–3 self-reported as healthy.
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Cohort 1 consisted of  donors participating in the following study: Genes and Mechanisms in Type 1 
Diabetes in the Cambridge BioResource recruited via the National Institute for Health Research (NIHR) 
Cambridge BioResource. Within cohort 1 are a group of  371 donors who were immunophenotyped for 
Figure 1B, Supplemental Figure 1A, Figure 2B, Supplemental Figure 2, A and B, Figure 5, B and C, and 
Supplemental Figure 5, A and B (114 males aged 19 to 72, median 47; 257 females aged 18 to 78, median 
46; all self-reported as healthy except for 4 female donors who self-reported a history of  autoimmune 
disease — 2 with autoimmune thyroid disease, 1 with vitiligo, and 1 with celiac disease). This cohort also 
includes an additional 20 donors (aged 18–65, 7 males and 13 females) who donated samples for the micro-
array analyses reported in Figure 1C, Supplemental Figure 5, C and D, and Supplemental Spreadsheet 1. 
An additional 3 donors (2 females, 40–44 years old, 1 female, 30–34 years old) provided samples for the 
RNA expression studies (NanoString and RNA-seq, Figure 4A, Figure 5D, Supplemental Tables 1 and 2, 
and Supplemental Spreadsheets 2–4). One donor (female, 40–44 years old) provided samples for sjTREC 
determinations shown in Figure 2C. Finally, 14 additional donors (age 26–67, 5 males and 9 females) from 
this study were assessed for CR1 levels in Figure 4B, Supplemental Figure 4B, and Figure 5E. The study 
was approved by NRES Committee East of  England - Norfolk (ref: 05/Q0106/20).
Cohort 2 consisted of  donors participating in the following study: Diabetes—Genes, Autoimmunity, 
and Prevention, a study of  newly diagnosed children with type 1 diabetes and nondiabetic siblings of  pro-
bands with type 1 diabetes. All 15 donors (7 males aged 5–16, 8 females aged 1–14) did not have diabetes 
and were negative for type 1 diabetes–related autoantibodies). These 15 donors contributed to the immu-
nophenotyping presented in Figure 1B, Supplemental Figure 1A, Figure 2B, Supplemental Figure 2, A and 
B, Figure 5, B and C, Supplemental Figure 5, A and B, Figure 4B, Supplemental Figure 4B, and Figure 5E.
Cohort 3 consisted of  donors participating in the following study: Investigating Genes and Phenotypes 
Associated with Type 1 Diabetes (8 cord blood samples; 7 adults, none with self-reported autoimmunity). 
Six adult donors (3 males and 3 females, 18–45 years of  age) provided samples for sjTREC determina-
tions shown in Figure 2C. One donor (female, 35–39) provided a sample for the RNA expression studies 
(NanoString and RNA-seq, Figure 4A, Figure 5D, Supplemental Tables 1 and 2, and Supplemental Spread-
sheets 2–4). Three adult donors (1 male and 2 females, 30–44 years of  age) provided samples for IL-8 and 
IL-2 protein production following activation in Figure 4C and Figure 5F. Three cord blood samples were 
utilized to assess IL-8 protein production in Figure 4D and were used for immunophenotyping in Figure 
1B, Supplemental Figure 1A, Figure 2B, Supplemental Figure 2, A and B, Figure 5, B and C, Supplemental 
Figure 5, A and B, Figure 4B, Supplemental Figure 4B, and Figure 5E. Immunophenotyping in Figure 1B, 
Figure 4B, Supplemental Figure 4B, and Figure 5E included 2 additional cord bloods.
The MS patients (6 females and 2 males, aged 27–49) studied longitudinally (Figure 3 and Supple-
mental Figure 3) were from the placebo arm (received alemtuzumab only, keratinocyte growth factor 
was not given) of  the trial “Keratinocyte Growth Factor - promoting thymic reconstitution and pre-
venting autoimmunity after alemtuzumab (Campath-1H) treatment of  multiple sclerosis” (REC refer-
ence: 12/LO/0393, EudraCT number: 2011-005606-30). An additional 11 adult MS patients studied 
in a cross-sectional manner were treated with alemtuzumab 6 to 9 months (n = 4, Figure 4D), 6 to 12 
months (n = 4, Supplemental Figure 3, A and C), or greater than 10 years (n = 3, Figure 4D) prior to 
sample donation (CAMSAFE REC 11/33/0007).
Diabetes—Genes, Autoimmunity, and Prevention was originally approved by the National Research 
Ethics Committee London – Hampstead, and is now held under the ethics of  Investigating Genes and 
Phenotypes Associated with Type 1 Diabetes, which was approved by NRES Committee East of  England 
- Cambridge Central (ref: 08/H0308/153). NIHR Cambridge BioResource donors were collected with the 
prior approval of  the National Health Service Cambridgeshire Research Ethics Committee. DBD, LSW, 
and JAT codesigned the Diabetes—Genes, Autoimmunity, and Prevention study. FWL helped organize the 
provision of  the blood samples in the Investigating Genes and Phenotypes Associated with Type 1 Diabetes 
study. JAT led the Investigating Genes and Phenotypes Associated with Type 1 Diabetes and Genes and 
Mechanisms of  Type 1 Diabetes in the Cambridge BioResource studies.
Study approval. Written informed consent was obtained from all participants or their guardians taking 
part in the study.
Whole blood and PBMC immunostaining. Blood samples were directly immunophenotyped within 5 hours 
following donation. Samples were blocked for 10 minutes with mouse IgG (20 μg/ml), stained for 40 minutes 
at room temperature with appropriate antibodies, and then lysed with freshly prepared 1× BD FACS Lysing 
Downloaded from http://insight.jci.org on September 13, 2017.   https://doi.org/10.1172/jci.insight.93739
1 3insight.jci.org   https://doi.org/10.1172/jci.insight.93739
R E S E A R C H  A R T I C L E
Solution (BD Biosciences). After lysis of  red blood cells, samples were washed with BD CellWASH (BD 
Biosciences). Finally, the samples were fixed with freshly prepared 1× BD CellFIX (BD Biosciences). The 
samples were stored at 4°C in the dark until analysis using a BD LSRFortessa flow cytometer. Peripheral 
blood mononuclear cell (PBMC) samples, prepared as previously described (42), were blocked for 10 minutes, 
stained for 1 hour at 4°C, washed twice, and fixed as described for peripheral blood immunophenotyping 
except for intracellular staining when surface-stained cells after the wash step were placed in FOXP3 Fix/
Perm buffer (eBioscience). Phenotyping panels are detailed in Supplemental Table 3. CD25 detection sensitiv-
ity was increased (42) by simultaneous application of  2 anti-CD25 monoclonal antibodies labeled with the 
same fluorochrome (clones 2A3 and M-A251, BD Biosciences). Antibody concentrations used were based on 
the manufacturer’s instructions as well as on optimization studies. Appropriate isotype controls and fluores-
cence-minus-one conditions were used during the development of  staining panels. Immunostained samples 
were analyzed on a BD LSRFortessa cell analyzer and data were visualized using FlowJo (Tree Star).
Cryopreserved PBMCs. PBMC isolation, cryopreservation, and thawing were performed as previously 
described (42). In brief, PBMC isolation was carried out using Lympholyte (CEDARLANE). PBMCs were 
cryopreserved in heat-inactivated, filtered human AB serum (Sigma-Aldrich) and 10% DMSO (Hybri-MAX, 
Sigma-Aldrich) at a final concentration of  10 × 106/ml and were stored in liquid nitrogen. Cells were thawed 
in a 37°C water bath for 2 minutes. PBMCs were subsequently washed by adding the cells to 10 ml of  cold 
(4°C) X-VIVO (Lonza) containing 10% AB serum per 10 × 106 cells, in a drop-wise fashion. PBMCs were 
then washed again with 10 ml of  cold (4°C) X-VIVO containing 1% AB serum per 10 × 106 cells.
T cell subset purification by cell sorting and DNA isolation. CD4+ T cells (RosetteSep Human CD4+ T Cell 
Enrichment Cocktail, STEMCELL Technologies) were washed and immediately incubated with antibod-
ies against surface molecules (Supplemental Table 3) for 40 minutes at 4°C, washed, and followed by sort-
ing on a BD FACSAria Fusion flow cytometer cell sorter) into X-VIVO medium (Lonza) containing 5% 
human AB serum (Sigma-Aldrich). In order to isolate DNA, sorted cell subsets were checked for purity and 
DNA was isolated using a DNA extraction reagent (QIAGEN).
sjTREC assay. The sjTREC assay was performed as described previously (8). A quantitative PCR 
assay was purchased from Sigma-Genosys for the sjTREC that arises through an intermediate rear-
rangement in the TCRD/TCRA locus in developing TCRαβ+ T lymphocytes. An assay for the gene 
encoding albumin was used to normalize the data. The following primers were used: sjTREC.F, 
TCGTGAGAACGGTGAATGAAG; sjTREC.R, CCATGCTGACACCTCTGGTT; sjTREC.P, FAM-
CACGGTGATGCATAGGCACCTGC-TAMRA; Alb.F, GCTGTCATCTCTTGTGGGCTGT; Alb.R, 
ACTCATGGGAGCTGCTGGTTC; Alb.P FAM-CCTGTCATGCCCACACAAATCTCTCC-TAMRA. 
For each sample, 24 ng of  DNA was incubated in duplicate with both primers (700 nM), probe (150 nM), 
and 12.5 μl TaqMan mastermix (Applied Biosystems) and processed using the Applied Biosystems 7900HT 
Fast Real-Time PCR System. sjTRECs were normalized to the albumin gene, representing cellular DNA, 
using the following formula: 2 (Ct [albumin] − Ct [sjTREC]).
T cell activation. FACS-purified T cell subsets or total CD4+ T cells (RosetteSep) for cord blood samples 
and samples from MS patients in Figure 4D were stimulated with either anti–CD3/CD28 beads (Life Tech-
nologies) at 3 cells per bead overnight (for RNA expression analyses) or cell stimulation reagent (PMA and 
ionomycin, eBioscience) in the presence of  protein transport inhibitors (eBioscience) for 6 hours at 37°C in 
96-well U-bottom plates (for intracellular cytokine determinations). IL-8+ and IL-2+ T cells were identified 
with a staining panel shown in Supplemental Table 3.
Microarray gene expression analysis. Total RNA was prepared from cell subsets isolated by sorting using 
TRIzol reagent (Life Technologies). Single-stranded cDNA was synthesized from 200 ng of  total RNA 
using the Ambion WT Expression kit (Ambion) according to the manufacturer’s instructions. Labeled 
cDNA (GeneChip Terminal Labeling and Hybridization Kit, Affymetrix) was hybridized to a 96 Titan 
Affymetrix Human Gene 1.1 ST array.
Power calculations to determine the sample size required were performed using the method of  Tib-
shirani (43), using a reference dataset from the Affymetrix GeneST array (deposited in ArrayExpress 
(http://www.ebi.ac.uk/arrayexpress/, accession number E-MTAB-4852) using the TibsPower package 
(http://github.com/chr1swallace/TibsPower) in R. We chose 20 pairs to have a false discovery rate 
(FDR) close to zero while detecting a 5-fold change in gene expression in 20 genes with a false nega-
tive rate of  5% or a 2-fold change in gene expression in 20 genes with a false negative rate of  40%, at a 
significance threshold of  10–6.
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Microarray gene expression log2 intensities were normalized using vsn2 (44). Analysis of  differential 
expression (log2 intensities) was conducted pairwise between each cell subtype using paired t tests with 
limma (45). P values were adjusted using the Benjamini-Hochberg algorithm. Illustrative principal com-
ponent analysis was performed on the union of  the most differentially expressed genes in each pairwise 
comparison. Data are deposited with ArrayExpress, accession number E-MTAB-4853.
NanoString and RNA-seq: sample preparation and data analysis. See Supplemental Figure 7 for a descrip-
tion of  the NanoString and RNA-seq experimental design. CR2+ and CR2− naive and memory cell subsets 
isolated by sorting CD4+ T cells (RosetteSep) from 4 donors were pelleted directly or following activation 
and lysed in QIAGEN RLT buffer and frozen at −80°C. To extract RNA, lysates were warmed to room 
temperature and vortexed. The RNA was extracted using a Zymo Research Quick-RNA MicroPrep kit fol-
lowing the manufacturer’s recommended protocol including on-column DNA digestion. RNA was eluted 
in 6 μl of  RNase-free water. NanoString RNA expression analysis was performed using the Human Immu-
nology v2 XT kit (NanoString Technologies), and 5 μl of  RNA (5 ng/μl) was used per hybridization and set 
up following the recommended XT protocol. Hybridization times for all samples were between 16 and 20 
hours. A NanoString Flex instrument was used and the Prep Station was run in high sensitivity mode and 
555 fields of  view were collected by the Digital Analyser. For RNA-seq analysis, 10 μl of  RNA (8 ng/μl) 
was processed by AROS Applied Biotechnology using the Illumina TruSeq Access method that captures 
the coding transcriptome after library prep.
Raw NanoString expression measurements were normalized with application of  NanoString software 
(nSolver 2.5). Subsequently, a paired differential expression analysis was carried out using DESeq2 v1.12.3 
(46), with preset size factors equal to 1 for all samples. Analyses were performed using an FDR of  0.05%. 
A missing FDR is reported for genes that were found to contain an expression outlier by DESeq2 Cook’s 
distance-based flagging of  P values. NanoString data are deposited with ArrayExpress, accession number 
E-MTAB-4834.
RNA-seq yielded on average 35.9 million paired-end reads per library. Maximum likelihood transcript 
read count estimates for each sample were obtained with Kallisto v0.42.5 (47), using Ensembl Release 
82 (48) as a reference transcriptome. Gene expression estimates were derived by aggregating all their 
constituent transcript read counts, which were then employed to perform a paired differential expression 
analysis using limma v3.28.5 (45). For RNA-seq data, limma estimates the mean-variance relationship of  
log-counts and a precision weight for each gene observation (replicate) is generated to moderate standard 
errors (49). Analyses were performed using an FDR of  0.05%. A missing FDR is reported for genes that 
did not contain at least 2 counts per million (CPM) in at least 2 samples. Data from RNA-seq have been 
deposited with the European Genome-phenome Archive, http://www.ebi.ac.uk/ega/, accession number 
EGAS00001001870.
Statistical analysis of  flow cytometry data interrogating T cell subsets. Statistical analyses of  flow cytometry 
data were performed and presented using Prism 5 software (GraphPad) unless otherwise stated. Compari-
sons between cell subsets were performed using a paired t test unless otherwise stated. P less than 0.05 was 
considered significant; error bars show the SD of  the samples at each test condition.
A nonparametric method, LOESS (50), performed with R software (http://www.R-project.org) was used 
to analyze some of  the datasets The gray zones define a 95% confidence interval for each regression line.
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